Separate names with a comma.
Decibel Therapeutics (now owned by Regeneron) has a similar drug and made a press release regarding similarly good news back in October. Both...
I decided to dig around and see if there was any news from DB-OTO study and I found this press release from Regeneron that indicated some initial...
Decibel Therapeutics announced this morning that they're being acquired by Regeneron. The deal is $4 per share plus $3.5 per share in CVR...
About 2 weeks before the FX-322's Phase 2b data release, the CEO retweeted these tweets: [ATTACH] I think this gives us the best insight into...
Gene therapy is one avenue that's being explored. The two main companies (that I'm aware of) in this space are Decibel Therapeutics and Akouos....
They did a one-year follow up on the Phase 1/2 trial participants and the effects at 90 days had significantly lessened. They did a similar long...
He was asked about this on Twitter and replied "No plan to do that. Not convinced that drug delivery was FX-322’s only challenge". I found this...
Elsewhere on Twitter he says (in regards to a hearing drug) "We’ve been testing a wide range of approaches in the lab. Might have something ready...
As I said in my previous post, their current drug candidate, SPT-2101, is dexamethasone - which is what Otonomy's Ovitidex was. If SPT-2101 shows...
I unfortunately can't find any info on it. I did find this press release though, which talks about the Phase 1 and Phase 2 studies of SPT-2101....
Great news everyone, the CEO of Spiral Therapeutics just tweeted that their plan is indeed to see if BDNF works with their delivery method....
They did, but they didn't expect a response from them, they just did them for safety reasons. Here's what they told me when I emailed them back in...
My guess is they'll take a close look at all of the data they're given to see if they think BDNF is viable to move forward with. I assume they're...
I don't know, the liquidation has been moving along though. I honestly don't expect us to hear much for a while. I still don't understand why one...
Two months ago Frequency Therapeutics did a story with CBS that featured a former trial patient saying they got "84%" of their hearing back. It's...
